CHLORAMPHENICOL SODIUM SUCCINATE (chloramphenicol sodium succinate) by Fresenius Kabi is clinical pharmacology: chloramphenicol administered orally is absorbed rapidly from the intestinal tract. Approved for surface ocular infections involving the conjunctiva and/or cornea caused by chloramphenicol-susceptible organisms. First approved in 1982.
Drug data last refreshed 22h ago
CLINICAL PHARMACOLOGY: Chloramphenicol administered orally is absorbed rapidly from the intestinal tract. In controlled studies in adult volunteers using the recommended dosage of 50 mg/kg/day, a dosage of 1 g every 6 hours for 8 doses was given. Using the microbiological assay method, the average…
Worked on CHLORAMPHENICOL SODIUM SUCCINATE at Fresenius Kabi? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.